A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

March 9, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

April 30, 2029

Conditions
Atopic DermatitisEczema
Interventions
DRUG

Lebrikizumab

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (94)

300

National Taiwan University Hospital - Hsinchu branch, Hsinchu

333

Chang Gung Medical Foundation-Linkou Branch, Taoyuan District

402

Chung Shan Medical University Hospital, Taichung

1012

CONEXA Investigacion Clinica S.A., Buenos Aires

1027

Centro de Investigaciones Metabólicas (CINME), Ciudad Autónoma de Buenos Aires

1425

Instituto de Neumonología Y Dermatología, Ciudad Autonoma de Buenos Aire

2031

Sydney Children's Hospital, Randwick

2145

The Children's Hospital at Westmead, Westmead

4102

Veracity Clinical Research Pty Ltd, Woolloongabba

4151

Cornerstone Dermatology, Coorparoo

10002

National Taiwan University Hospital, Taipei

11217

Taipei Veterans General Hospital, Taipei

26102

Hôpitaux Drôme Nord - Romans, Romans-sur-Isère

28006

Grupo Pedro Jaén, Madrid

28009

Hospital Infantil Universitario Niño Jesús, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

28046

Hospital Universitario La Paz, Madrid

28223

Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón

29425

Medical University of South Carolina, Charleston

31008

Clinica Universidad de Navarra, Pamplona

31207

Scientia Investigacion Clinica S.C., Chihuahua City

31400

CHU de Toulouse - Hopital Larrey, Toulouse

32256

Solutions Through Advanced Research, Jacksonville

33613

ForCare Clinical Research, Tampa

35010

Hospital Universitario de Gran Canaria Doctor Negrín, Las

35209

Clinical Research Center of Alabama, Birmingham

36001

CHOP-Centro De Especialidades De Mollabao, Pontevedra

42301

Allergy and Asthma Specialist, Owensboro

45190

Instituto Dermatologico de Jalisco, Zapopan

45324

Wright State Physicians, Fairborn

46940

Hospital de Manises, Manises

48149

Universitätsklinikum Münster, Münster

48197

Respiratory Medicine Research Institute of Michigan, PLC, Ypsilanti

48455

Fachklinik Bad Bentheim, Bad Bentheim

48706

Great Lakes Research Group, Inc., Bay City

53226

Medical College of Wisconsin, Milwaukee

59020

Hôpital Saint Vincent-de-Paul, Lille

60590

Universitätsklinikum Frankfurt, Frankfurt am Main

60611

Northwestern University, Chicago

62290

PanAmerican Clinical Research - Cuernavaca, Cuernavaca

64283

Rosenpark Research GmbH, Darmstadt

64718

Eukarya PharmaSite, Monterrey

66460

"Hospital Universitario Dr. Jose Eleuterio Gonzalez", Monterrey

72217

Arkansas Research Trials, North Little Rock

77401

The University of Texas Health Science Center at Houston, Bellaire

78218

Texas Dermatology and Laser Specialists, San Antonio

83301

Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung Niao Sung Dist

83706

Treasure Valley Medical Research, Boise

85016

Phoenix Children's Hospital, Phoenix

90045

Dermatology Research Associates, Los Angeles

91910

Arké SMO S.A de C.V, Veracruz

92708

First OC Dermatology, Fountain Valley

95815

Integrative Skin Science and Research - Location 2, Sacramento

14784400

Fundação Pio XII - Hospital de Câncer de Barretos, Barretos

06030

UConn Health, Farmington

02114

Massachusetts General Hospital, Boston

03766

Dartmouth-Hitchcock Medical Center, Lebanon

C1425DKG

Psoriahue, Ciudad Autonoma de Buenos Aire

C1121ABE

Fundacion Cidea, Buenos Aires

S2000DEJ

Fundacion Estudios Clinicos, Rosario

C1426ABP

Fundación Respirar, Buenos Aires

90035-903

Hospital de Clinicas de Porto Alegre, Porto Alegre

13060-803

Centro de Pesquisa Sao Lucas, Campinas

14051-140

Hospital de Clínicas de Ribeirão Preto, Ribeirão Preto

09060-870

Faculdade de Medicina do ABC, Santo André

09080-110

Pesquisare Saude, Santo André

18040-425

Clinica de Alergia Martti Antila, Sorocaba

20241-180

IBPClin - Instituto Brasil de Pesquisa Clínica, Rio de Janeiro

T2J 7E1

Dermatology Research Institute, Calgary

L4Y 4C5

DermEdge Research, Mississauga

613 00

Detska nemocnice FN Brno, Brno

180 81

Fakultni nemocnice Bulovka, Prague

44093 Cedex 1

Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu, Nantes

01307

Universitaetsklinikum Carl Gustav Carus Dresden, Dresden

470-1192

Fujita Health University, Toyoake

721-8511

Fukuyama City Hospital, Fukuyama

078-8510

Asahikawa Medical College Hospital, Asahikawa

252-0315

National Hospital Organization Sagamihara National Hospital, Sagamihara

396-0033

Ina Central Hospital, Ina

583-8588

Osaka Habikino Medical Center, Habikino

593-8324

Dermatology and Ophthalmology Kume Clinic, Sakai

360-0018

Enomoto Clinic, Kumagaya

170-0002

Sugamo Sengoku Dermatology, Toshima City

734-8551

Hiroshima University Hospital, Hiroshima

602-8566

University Hospital,Kyoto Prefectural University of Medicine, Kyoto

700-8557

Okayama City General Medical Center Okayama City Hospital, Okayama

06090

Hospital de Jesús Nazareno, Mexico City

06700

Trials in Medicine, Mexico City

06720

Hospital Infantil de Mexico Federico Gomez, Mexico City

02-625

Centrum Medyczne Evimed, Warsaw

31-559

Diamond Clinic, Krakow

80-546

Centrum Badan Klinicznych PI-House sp. z o.o., Gdansk

90-265

DERMED Centrum Medyczne Sp. z o.o., Lodz

08950

Hospital Sant Joan de Déu, Esplugues de Llobregat

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY